About Index Trending news
Analyze
Top 50 Pricing
Stemgent

Stemgent

Work at Stemgent? Add yourself to this profile

Stemgent

Stemgent is a leading supplier providing mRNA reprogramming systems, cell culture media, antibodies, small molecules, and iPS reprogramming services.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Debt financing
$2,700,000
Morgenthaler Ventures, HealthCare Ventures
Venture capital (Series B)
$14,000,000
Employees

Team size

50+

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Stemgent makes some noise.